Bone Biologics Corporation (BBLG)
BBLG Stock Price Chart
Explore Bone Biologics Corporation interactive price chart. Choose custom timeframes to analyze BBLG price movements and trends.
BBLG Company Profile
Discover essential business fundamentals and corporate details for Bone Biologics Corporation (BBLG) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
13 Oct 2021
Employees
2.00
Website
https://www.bonebiologics.comCEO
Jeffrey Frelick
Description
Bone Biologics Corporation, a medical device enterprise, specializes in fostering bone regeneration for spinal fusion, leveraging its advanced recombinant human protein technology. Its flagship product, NELL-1/DBX, is a unique combination of an osteostimulative recombinant protein designed for precise, targeted control over bone regrowth. The company is currently advancing the NELL-1/DBX Fusion Device, intended for spinal fusion interventions in skeletally mature individuals experiencing single-level degenerative disc disease within the L4-S1 spinal segments. This versatile platform technology also holds the potential to deliver superior outcomes across a wide spectrum of surgical specialties, including spinal, various orthopedic fields, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. Bone Biologics holds a licensing agreement with the UCLA Technology Development Group, which authorizes the development and commercialization of NELL-1 for its spinal fusion applications. The firm was established in 2004 and is based in Burlington, Massachusetts.
BBLG Financial Timeline
Browse a chronological timeline of Bone Biologics Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 Aug 2026
EPS estimate is -$0.39.
Earnings released on 14 May 2026
EPS came in at -$0.43 matching the estimated -$0.43.
Earnings released on 2 Mar 2026
EPS came in at -$0.14 surpassing the estimated -$0.34 by +58.82%.
Earnings released on 14 Nov 2025
EPS came in at -$0.37 surpassing the estimated -$1.23 by +69.92%.
Earnings released on 14 Aug 2025
EPS came in at -$1.33 falling short of the estimated -$0.58 by -129.31%.
Stock split effective on 10 Jun 2025
Shares were split 1 : 6 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 12 May 2025
EPS came in at -$1.92 falling short of the estimated -$0.48 by -300.00%.
Earnings released on 5 Mar 2025
EPS came in at -$0.61 surpassing the estimated -$0.65 by +6.15%.
Earnings released on 14 Nov 2024
EPS came in at -$14.22 falling short of the estimated -$3.60 by -295.00%.
Earnings released on 9 Aug 2024
EPS came in at -$4.02 surpassing the estimated -$8.34 by +51.80%.
Earnings released on 14 May 2024
EPS came in at -$7.86 surpassing the estimated -$45.59 by +82.76%.
Earnings released on 4 Apr 2024
EPS came in at -$2.47 surpassing the estimated -$5.60 by +55.89%.
Stock split effective on 20 Dec 2023
Shares were split 1 : 8 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Nov 2023
EPS came in at -$29.27 surpassing the estimated -$145.89 by +79.94%.
Earnings released on 14 Aug 2023
EPS came in at -$81.10 falling short of the estimated -$71.99 by -12.65%.
Stock split effective on 7 Jun 2023
Shares were split 1 : 30 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 15 May 2023
EPS came in at -$331.47 surpassing the estimated -$2.16k by +84.67%.
Earnings released on 30 Mar 2023
EPS came in at $144.12 surpassing the estimated -$0.22 by +65.61k%.
Earnings released on 14 Nov 2022
EPS came in at -$172.94 surpassing the estimated -$360.29 by +52.00%.
Earnings released on 11 Aug 2022
EPS came in at -$72.06 surpassing the estimated -$172.94 by +58.33%.
Earnings released on 13 May 2022
EPS came in at -$100.88 surpassing the estimated -$288.23 by +65.00%.
Earnings released on 15 Mar 2022
EPS came in at -$4.13 falling short of the estimated -$0.17 by -2.33k%.
Earnings released on 16 Nov 2021
EPS came in at -$9.95 .
Stock split effective on 13 Oct 2021
Shares were split 1 : 2 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 16 Aug 2021
EPS came in at -$9.62 .
BBLG Stock Performance
Access detailed BBLG performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
